Table 3.
Normal UA | Higher UA | p-value | |
---|---|---|---|
Index PCI | |||
n | 257 | 71 | |
Pre-procedural RVD (mm) | 2.9 ± 0.4 | 3.0 ± 0.5 | 0.055 |
Pre-procedural MLD (mm) | 0.6 ± 0.4 | 0.6 ± 0.4 | 0.396 |
Pre-procedural DS (mm) | 79.0 ± 12.6 | 78.5 ± 12.4 | 0.749 |
Pre-procedural lesion length (mm) | 20.1 ± 11.0 | 20.2 ± 10.2 | 0.959 |
Post-procedural MLD (mm) | 2.7 ± 0.4 | 2.8 ± 0.6 | 0.105 |
Post-procedural DS (%) | 8.6 ± 6.8 | 8.5 ± 11.9 | 0.925 |
Acute gain (mm) | 2.1 ± 0.5 | 2.2 ± 0.6 | 0.293 |
Follow-up CAG | |||
n | 118 | 32 | |
Median follow-up period (day) | 462 | 527 | 0.559 |
Target lesion RVD (mm) | 2.9 ± 0.5 | 2.9 ± 0.5 | 0.888 |
Target lesion MLD (mm) | 1.9 ± 1.1 | 2.0 ± 1.1 | 0.590 |
Target lesion DS (%) | 36.2 ± 34.2 | 33.4 ± 33.0 | 0.686 |
Late lumen loss (mm) | 0.8 ± 1.1 | 0.8 ± 0.9 | 0.895 |
Binary restenosis, n (%) | 41 (34.7) | 9 (28.1) | 0.622 |
Data were presented as n (%) or mean ± SD. PCI, percutaneous coronary intervention; UA, uric acid; CAG, coronary angiography; RVD, reference vessel diameter; MLD, minimal lumen diameter; DS, diameter stenosis